IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,656,000 | +53.1% | 118,228 | +17.3% | 0.00% | +50.0% |
| Q3 2016 | $3,695,000 | -67.9% | 100,831 | -79.6% | 0.00% | -66.7% |
| Q2 2016 | $11,522,000 | -62.6% | 494,694 | -35.0% | 0.01% | -64.7% |
| Q1 2016 | $30,836,000 | -41.4% | 761,363 | -10.4% | 0.02% | -41.4% |
| Q4 2015 | $52,620,000 | – | 849,678 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |